Materias dentro de su búsqueda.
Mostrando 1,521 - 1,540 Resultados de 15,180 Para Buscar '"Hepatitis C"', tiempo de consulta: 0.47s Limitar resultados
  1. 1521
    “…Hepatitis C virus (HCV) is estimated to affect up to 150 million people worldwide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis C
  2. 1522
    por Sundaram, Vinay, Kowdley, Kris V
    Publicado 2016
    “…Chronic hepatitis C virus (HCV) infection is one of the most common etiologies of liver-related mortality throughout the world. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection
  3. 1523
    “…Background. Hepatitis C (HCV) is the most common chronic blood-borne infection in the United States and affects Asian and non-Asian Americans comparably. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis C Is Poorly Associated With Drug Use in Cambodian Americans in Lowell, Massachusetts
  4. 1524
    “…Antiviral therapy for recurrent hepatitis C in liver transplant recipients has been associated with low efficacy, poor tolerability, and drug-drug interactions. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Infection After Liver Transplantation
  5. 1525
    “…BACKGROUND AND AIM: To investigate the impact of a sustained virological response (SVR) to hepatitis C virus (HCV) treatment on liver stiffness (LS). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Liver Stiffness Decreases Rapidly in Response to Successful Hepatitis C Treatment and Then Plateaus
  6. 1526
    “…BACKGROUND: To fully understand the burden of hepatitis C (HCV) infection in Ghana towards informing appropriate preventive measures, accurate prevalence estimates are needed. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis
  7. 1527
    “…PURPOSE: Peg-interferon (PegIFN)α2a or PegIFNα2b plus ribavirin (RBV) is the standard therapy for chronic hepatitis C virus (HCV) infection in Taiwan and Asia. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Anti-Viral Therapy and Decreased Sexual Desire in Patients with Chronic Hepatitis C
  8. 1528
    “…Unfortunately, the impact of CNV on a number of diseases, including hepatitis C virus (HCV) infection, remains largely unexplored. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Copy number variation of genes involved in the hepatitis C virus-human interactome
  9. 1529
    “…BACKGROUND: Hepatitis C virus (HCV) affects an estimated number of people between 130 million and 210 million worldwide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives
  10. 1530
    “…We aimed to examine the relationship between serum HA level and PEM in patients with chronic hepatitis C (CHC) compared with the relationships of other serum markers of fibrosis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C
  11. 1531
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Correction: Retinopathy and Uveitis Associated with Sofosbuvir Therapy for Chronic Hepatitis C Infection
  12. 1532
    “…The Asian Pacific Association for the Study of the Liver (APASL) convened an international working party on “APASL consensus statements and recommendations for management of hepatitis C” in March 2015 to revise the “APASL consensus statements and management algorithms for hepatitis C virus infection” (Hepatol Int 6:409–435, 2012). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing
  13. 1533
    “…BACKGROUND: Anti-hepatitis C virus antibody (anti-HCV) assays are recommended for screening HCV-infected persons. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evaluation of the VIDAS Anti-HCV Assay for Detection of Hepatitis C Virus Infection
  14. 1534
    “…We compared effectiveness and safety of real world hepatitis C patients eligible and ineligible for registration trials. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Limited Generalizability of Registration Trials in Hepatitis C: A Nationwide Cohort Study
  15. 1535
    “…Chronic infections with hepatitis B (HBV) and hepatitis C viruses (HCV) are the leading cause of cirrhosis and hepatocellular carcinoma (HCC) worldwide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections
  16. 1536
    “…INTRODUCTION: Chronic hepatitis C (CHC) infection is a systemic disorder that can lead to liver inflammation, fibrosis, cirrhosis, and hepatocellular cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The effect of standard therapy on mean platelet volume in patients with chronic hepatitis C
  17. 1537
    “…Hepatitis C recurrence continues to present a major challenge in liver transplantation (LT). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Fibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantation
  18. 1538
    “…Hispanics have a disproportionately high prevalence of hepatitis C virus (HCV)-related morbidity and mortality. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Predictors of hospital re-admissions among Hispanics with hepatitis C-related cirrhosis
  19. 1539
    “…Hepatitis C virus (HCV) infection is a major public health burden in Europe, causing an increasing level of liver-related morbidity and mortality, characterized by several regional variations in the genotypes distribution. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe
  20. 1540
    “…The association of hepatitis C virus (HCV) and B-cell non-Hodgkin lymphomas (NHL) has been highlighted by several epidemiological and biological insights; however the most convincing evidence is represented by interventional studies demonstrating the capability of antiviral treatment (AT) with interferon (IFN) with or without ribavirin to induce the regression of indolent lymphomas, especially of marginal-zone origin. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma
Herramientas de búsqueda: RSS